This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2

NCT03566238 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

PFIC1
PFIC2

Interventions

DRUG: A4250 (odevixibat)
DRUG: Placebo

Sponsor

Albireo